Medical/Pharmaceuticals
AcuraBio expands cGMP plasmid DNA CDMO services with Cytiva's latest single-use purification technology to alleviate supply constraints for mRNA and cell & gene therapies
* AcuraBio selects Cytiva's latest two-step purification protocol to offer a productive plasmid DNA service to its customers globally to alleviate supply constraints for mRNA and cell & gene therapies * The latest purification technology will offer efficient processing time for plasmid DNA pr...
2023-02-10 04:34
4003
Syntach AB announces partnership with Meditrial CRO to drive clinical development of groundbreaking Cardiac Support System
LUND, Sweden, Feb. 10, 2023 /PRNewswire/ - Syntach AB ("Syntach") is pleased to announce that it has entered into a partnership agreement with Meditrial Europe Ltd ("Meditrial") to support the clinical and regulatory strategies of Syntach's innovative minimally invasive cardiac support system. ...
2023-02-10 03:00
4296
US based COBRA diagnostic prostate cancer trial reaches recruitment target
SYDNEY, Feb. 9, 2023 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce its diagnostic 64Cu SAR-...
2023-02-09 22:03
3295
Hugel Achieved Record-High Revenue and Operating Profit
* Hugel delivered 2022 revenue of KRW281.7bn, operating profit of KRW102.5bn, up 21.5% YoY and 7.2% YoY, respectively * Botulinum toxin's sales soared by 28.9% YoY; European sales in full swing * Hugel aims to obtain marketing approval and launch products in the U.S. within this year SEOUL, ...
2023-02-09 22:00
3864
First Prescription for COSELA® (trilaciclib) Issued in China
- COSELA®, the world's first and only myeloprotection drug, was prescribed in Jilin Cancer Hospital onJanuary 28, 2023 - Simcere delivers drug to patients in 908 days from execution of license agreement to first prescription NANJING, China, Feb. 9, 2023 /PRNewswire/ -- Simcere Pharmaceutical Gr...
2023-02-09 21:00
4300
Technoderma Medicines Initiates TDM-180935 Atopic Dermatitis Clinical Program with Phase 1 Dose Escalation Trial
SAN DIEGO, Feb. 9, 2023 /PRNewswire/ -- Technoderma Medicines, Inc. ("the Company"), a clinical stage biopharmaceutical company, is pleased to report the Company has begun dosing healthy volunteer subjects in its Phase 1 clinical trial of topical TDM-180935 ointment. This first clinical trial in ...
2023-02-09 21:00
2320
AnPac Bio-Medical Science Enters into Definitive Agreement to Acquire Fresh2 Ecommerce Inc, a B2B Asian Food E-commerce Platform
Transaction expected to fuel the Company's growth in the U.S. food market NEW YORK, Feb. 9, 2023 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. (the "Company") (NASDAQ: ANPC), a company with operations inthe United States andChina focused on early cancer screening and detection and plans to ...
2023-02-09 21:00
4051
DNA Data Company, Asa Ren, Raised An Oversubscribed US$8.15M To Build An Indonesia Population DNA Database
JAKARTA, Indonesia, Feb. 9, 2023 /PRNewswire/ -- Asa Ren, a leading DNA data company based inIndonesia, today announced the closing of a new early stage round of fundings ofUS$ 8.15 Million. This oversubscribed round was co-led by Top Harvest Capital (Silicon ValleyUSA), Kejora Capital (Kejora...
2023-02-09 18:27
5125
GC Biopharma Receives WHO Pre-Qualification for Filling and Finish Plant in Ochang, South Korea
YONGIN, South Korea, Feb. 8, 2023 /PRNewswire/ -- GC Biopharma (006280.KS), a leading provider of biopharmaceutical products inSouth Korea, announced today that the World Health Organization (WHO) has awarded prequalification to filling and finish plant onFebruary 3 2023, located in Ochang, South...
2023-02-09 09:21
2781
The National Cancer Society of Malaysia (NCSM), MSD and DoctorOnCall Collaborate In Conjunction with World Cancer Day 2023 to Offer Affordable Health Screenings to Members of the Public
KUALA LUMPUR, Malaysia, Feb. 9, 2023 /PRNewswire/ -- In conjunction with World Cancer Day 2023, The National Cancer Society ofMalaysia (Persatuan Kanser Kebangsaan Malaysia) (NCSM), MSD and DoctorOnCall are collaborating to increase public awareness with regard to cancer by offering free basic he...
2023-02-09 08:00
4937
ImmVira Clinical Snapshot: Intratumoral Injected OV (MVR-T3011 IT) Monotherapy Achieved Median PFS of 12.9 Months on Treatment of Melanoma
SHENZHEN, China, Feb. 8, 2023 /PRNewswire/ -- ImmVira's first intratumoral injected OV product MVR-T3011 IT has shown positive efficacy in the course of clinical studies in the U.S. andChina as of January 2023, with which the monotherapy treatment significantly prolonged PFS to a median of 12.9 m...
2023-02-09 08:00
2590
The world's oldest living lab rat points the way to rejuvenation
"Sima", a 47 months-old female rat, is being treated with E5, a treatment intended to recreate the circulatory environment of a young mammal; the maximum recorded lifespan for this species is 45.5 months. MOUNTAIN VIEW, Calif., Feb. 9, 2023 /PRNewswire/ -- An experiment led by Dr. Harold Katcher...
2023-02-09 05:00
3832
Halucenex Life Sciences Inc. targets Australian market following landmark TGA decision
The wholly-owned Creso Pharma subsidiary is currently conducting clinical trials of its synthetic psilocybin formulation as treatment for mental health conditions NEDLANDS, Australia, Feb. 9, 2023 /PRNewswire/ -- Creso Pharma Limited (ASX:CPH, FRA:1X8) ('Creso Pharma') is pleased to announce its ...
2023-02-09 04:04
3391
ReviR Therapeutics and Asieris Pharmaceuticals Enter into Agreement to Discover Oncology Therapeutics Based on ReviR's Comprehensive Approach to RNA-targeted Technologies
SAN FRANCISCO, Feb. 8, 2023 /PRNewswire/ -- ReviR Therapeutics, a privately held developer of a suite of small molecule RNA-targeting technologies for cancer and other genetically-defined diseases, and Asieris Pharmaceuticals, a global biopharma company specializing in discovering, developing, an...
2023-02-08 22:00
3244
SUMMIT HEALTHCARE ACQUISITION CORP. AND YS BIOPHARMA ANNOUNCE EFFECTIVENESS OF REGISTRATION STATEMENT AND EXTRAORDINARY GENERAL MEETING DATE FOR PROPOSED BUSINESS COMBINATION
* Extraordinary general meeting of Summit Healthcare Acquisition Corp.'s shareholders to be held onMarch 1, 2023 at 9:00 a.m. Eastern Time * YS Biopharma is a global biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines a...
2023-02-08 21:30
3960
SUMMIT HEALTHCARE ACQUISITION CORP. AND YS BIOPHARMA ANNOUNCE EFFECTIVENESS OF REGISTRATION STATEMENT AND EXTRAORDINARY GENERAL MEETING DATE FOR PROPOSED BUSINESS COMBINATION
* Extraordinary general meeting of Summit Healthcare Acquisition Corp.'s shareholders to be held onMarch 1, 2023 at 9:00 a.m. Eastern Time * YS Biopharma is a global biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines a...
2023-02-08 21:30
3903
Lunit and Agfa HealthCare bring breast imaging AI solution to Dubai Academic Health Corporation (DAHC) Dubai Hospital
* Dubai Academic Health Corporation (DAHC) Dubai Hospital to modernize its Breast Cancer Diagnostic and Screening program with Agfa HealthCare's RUBEE for AI framework and Lunit INSIGHT MMG algorithm * The Breast AI Analysis Package is Lunit's first application with Agfa HealthCare since form...
2023-02-08 21:05
3404
Meihua International Medical Technologies Co. Explores Application of ChatGPT Technologies to Develop Online AI Health Consultation Services
YANGZHOU, China, Feb. 8, 2023 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries inChina, today announced the Company will...
2023-02-08 20:30
2421
SK bioscience Announces the Largest Investment Ever to Establish Songdo Global Research & Process Development Center
* The additional investment for the 'R&PD Center' was confirmed by the board of directors committee with a total of261 million USD * SK bioscience plans to establish a vaccine-biopharmaceutical hub, organizing a global cooperative model against new pandemics SEONGNAM, South Korea, Feb. 8, 202...
2023-02-08 20:00
3188
A Joint Collaboration Between Bio Immunitas and GenScript ProBio Leads to the Development and Fast Track Manufacturing of A Novel Therapeutic Platform
NANJING, China, Feb. 8, 2023 /PRNewswire/ -- GenScript ProBio, a leading Biologics CDMO to the bio-pharmaceutical market, and Bio Immunitas, a UK pharmaceutical company with a novel, safe and efficacious human Recombinant Protein Platform (hRPP), announced their partnership to enhance an already ...
2023-02-08 17:00
2928
Week's Top Stories
Most Reposted
Cyient, 3-GIS Partner to Help Telecom and Utility Operators Turn Network Data into Operational Control
[Picked up by 1154 media titles]
2026-11-11 22:00Royal Bank of Canada announces agreement to acquire Yarra Capital Management
[Picked up by 1143 media titles]
2026-11-09 21:00Algolia Powers Orange with AI Agents for Billing Support: NYSE Content Update
[Picked up by 1121 media titles]
2026-11-06 22:06
Cision Report Reveals the Consumer Trends Hidden Between Search, Social, and AI
[Picked up by 1109 media titles]
2026-11-09 23:00
Poppi Founders Launch Hydration Brand jetty: NYSE Content Update
[Picked up by 1083 media titles]
2026-11-10 22:17
Most Read
DomoAI Launches InkoAI Agent - One Sentence to Ready-to-Post Video
2026-11-13 13:00
104880
Home Companion Robot Mobo to Debut Globally and Open Pre-orders as AiMOGA Showcases Its Robot Family at the 2026 OMODA & JAECOO International User Summit
2026-11-07 13:49
27630
SILVERSEA MARKS HISTORIC OPENING OF THE CORMORANT AT 55 SOUTH, THE SOUTHERNMOST HOTEL ON EARTH, OFFERING A NEW GATEWAY TO ANTARCTICA
2026-11-07 01:05
15903
